semaglutide and cirrhosis Gets FDA Greenlight for MASH New GLP-1 research to watch:

Weight loss surgery is often a solution

In this randomized, double-blind, placebo controlled trial, researchers attempt to understand if semaglutide treatment in patients greater than 50 years of age with established cardiovascular disease was noninferior to placebo with regards to cardiovascular death, nonfatal MI and/or stroke

If its approved, it could expand the range of options available and offer another path for people who havent responded to existing treatments

Semaglutide, a GLP-1 receptor agonist originally developed for type 2 diabetes, activates brain centers that regulate hunger and blood sugar

Kojic Acid Face Wash For Reduces Dark Spots & Pigmentation Here's where it gets interestingkojic acid isn't just about brightening

We are trying to obtain a biopsy and have a better description of this reaction, she says